Director of Metabolism and Lipids
Mount Sinai Health System
New York, New York, United States
Robert S. Rosenson, MD, is Professor of Medicine at the Icahn School of Medicine at Mount Sinai, and Director of Metabolism and Lipids for the Mount Sinai Health System, New York, New York. He is the recipient of numerous awards and honors, including the Ground-Breaking Doctors Award from Chicago magazine, New York Top Doc from 2015 to 2023 and USA Top Doctor in 2019. He is a 7 time recipient of the Simon Dack Award for outstanding scholarship by the Journal of the American College of Cardiology from 2015 to 2023. The International Academy of Cardiology honored him with the Jan J. Kellerman Memorial Award in 2016 for distinguished contributions in the field of cardiovascular disease prevention. UpToDate recognized him for 20 years of Outstanding Contributions as Editor, and the National Lipid Associaton awarded him the Clinician Educator Award from the National Lipid Association.
Saturday, February 25, 2023
1:30 PM – 1:45 PM ET
Disclosure information not submitted.
Saturday, February 25, 2023
4:14 PM – 4:22 PM ET
Disclosure(s): Amgen: Consulting Fees (e.g., advisory boards) (Ongoing), Grants/Research Support Recipient (Ongoing); Arrowhead: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); CRISPR Theraptucis: Consulting Fees (e.g., advisory boards) (Ongoing); Eli Lilly: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Kowa Pharmaceuticals: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Novartis: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Precision BioSciences: Consultant/Advisory Board (Ongoing); Regeneron: Consultant (Ongoing), Grant/Research Support (Ongoing); Verve Therapeutics: Consultant (Ongoing); Wolters Kluwer Health: Royalties (Ongoing)